Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Nov 30:4:191-200.
doi: 10.4137/bmi.s2557.

Protein modifications as potential biomarkers in breast cancer

Affiliations

Protein modifications as potential biomarkers in breast cancer

Hongjun Jin et al. Biomark Insights. .

Abstract

A variety of post-translational protein modifications (PTMs) are known to be altered as a result of cancer development. Thus, these PTMs are potentially useful biomarkers for breast cancer. Mass spectrometry, antibody microarrays and immunohistochemistry techniques have shown promise for identifying changes in PTMs. In this review, we summarize the current literature on PTMs identified in the plasma and tumor tissue of breast-cancer patients or in breast cell lines. We also discuss some of the analytical techniques currently being used to evaluate PTMs.

Keywords: PTMs; biomarkers; breast cancer; post-translational modifications.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Golks A, Guerini D. The O-linked N-acetylglucosamine modification in cellular signalling and the immune system. ‘Protein modifications: beyond the usual suspects’ review series. EMBO Rep. 2008 Aug;9(8):748–53. - PMC - PubMed
    1. Hoffman MD, Sniatynski MJ, Kast J. Current approaches for global post-translational modification discovery and mass spectrometric analysis. Anal Chim Acta. 2008 Oct 3;627(1):50–61. - PubMed
    1. Janke C, Rogowski K, van DJ. Polyglutamylation: a fine-regulator of protein function? ‘Protein Modifications: beyond the usual suspects’ review series. EMBO Rep. 2008 Jul;9(7):636–41. - PMC - PubMed
    1. Krueger KE, Srivastava S. Posttranslational protein modifications: current implications for cancer detection, prevention, and therapeutics. Mol Cell Proteomics. 2006 Oct;5(10):1799–810. - PubMed
    1. Hanash SM, Pitteri SJ, Faca VM. Mining the plasma proteome for cancer biomarkers. Nature. 2008 Apr 3;452(7187):571–9. - PubMed

LinkOut - more resources